The present disclosure generally relates to the field of reinforcement of surgical pads used in proximity to tissue openings. Surgical tethers can be anchored to a target tissue as a part of medical procedures for treating various health conditions. Anchoring surgical tethers to the heart wall can be a part of heart valve repair procedures to address a number of heart valve abnormalities. The surgical tethers can be anchored to the heart wall so as to maintain a desired tension in the surgical tethers.
In some examples, described herein are systems and methods relating to reinforced surgical pad devices comprising a reinforcement member and a surgical pad configured to be associated with the reinforcement member, including a central portion of the reinforcement member. For example, the surgical pad can be configured to be coupled to the reinforcement member, including a central portion of the reinforcement member. The reinforcement member and surgical pad can be configured to be positioned at least partially over an externally oriented surface of a target tissue and an opening formed in the target tissue. One or more tethers extending from the opening in the target tissue can be coupled to the surgical pad and/or reinforcement member. The reinforcement member can provide mechanical reinforcement and/or support to reduce or eliminate deformation of the surgical pad. In some instances, the reinforcement member can comprise one or more portions configured to extend laterally beyond an outer edge of the surgical pad, to thereby provide a larger area over which forces exerted upon the surgical pad by the tethers coupled thereto can be distributed. Distribution of forces exerted upon the surgical pad over a wider area can thereby reduce or prevent warping of the surgical pad due to concentrated force exerted thereupon by the one or more tethers.
Methods and structures disclosed herein for treating a patient also encompass analogous methods and structures performed on or placed on a simulated patient, which is useful, for example, for training; for demonstration; for procedure and/or device development; and the like. The simulated patient can be physical, virtual, or a combination of physical and virtual. A simulation can include a simulation of all or a portion of a patient, for example, an entire body, a portion of a body (e.g., thorax), a system (e.g., cardiovascular system), an organ (e.g., heart), or any combination thereof. Physical elements can be natural, including human or animal cadavers, or portions thereof; synthetic; or any combination of natural and synthetic. Virtual elements can be entirely in silica, or overlaid on one or more of the physical components. Virtual elements can be presented on any combination of screens, headsets, holographically, projected, loud speakers, headphones, pressure transducers, temperature transducers, or using any combination of suitable technologies.
For purposes of summarizing the disclosure, certain aspects, advantages and novel features have been described herein. It is to be understood that not necessarily all such advantages may be achieved in accordance with any particular example. Thus, the disclosed examples may be carried out in a manner that achieves or optimizes one advantage or group of advantages as taught herein without necessarily achieving other advantages as may be taught or suggested herein.
Various examples are depicted in the accompanying drawings for illustrative purposes and should in no way be interpreted as limiting the scope of the disclosure. In addition, various features of different disclosed examples can be combined to form additional examples, which are part of this disclosure. Throughout the drawings, reference numbers may be reused to indicate correspondence between reference elements. However, it should be understood that the use of similar reference numbers in connection with multiple drawings does not necessarily imply similarity between respective examples associated therewith. Furthermore, it should be understood that the features of the respective drawings are not necessarily drawn to scale, and the illustrated sizes thereof are presented for the purpose of illustration of inventive aspects thereof. Generally, certain of the illustrated features may be relatively smaller than as illustrated in some examples or configurations.
The headings provided herein are for convenience only and do not necessarily affect the scope or meaning of the claims.
In some examples, the present disclosure relates to systems and methods relating to reinforced surgical pad devices comprising a reinforcement member and a surgical pad configured to be associated with the reinforcement member, such as a central portion of the reinforcement member. A reinforced surgical pad device can be positioned over an opening in a target tissue such that one or more tethers extending from the opening in the target tissue can be secured to the surgical pad and/or reinforcement member. The reinforcement member can comprise one or more portions configured to extend laterally beyond an outer edge of the surgical pad, to thereby provide a larger area over which forces exerted upon the surgical pad by the tethers coupled thereto can be distributed.
Although certain preferred examples are disclosed below, inventive subject matter extends beyond the specifically disclosed examples to other alternative examples and/or uses and to modifications and equivalents thereof. Thus, the scope of the claims that may arise herefrom is not limited by any of the particular examples described below. For example, in any method or process disclosed herein, the acts or operations of the method or process may be performed in any suitable sequence and are not necessarily limited to any particular disclosed sequence. Various operations may be described as multiple discrete operations in turn, in a manner that may be helpful in understanding certain examples; however, the order of description should not be construed to imply that these operations are order dependent. Additionally, the structures, systems, and/or devices described herein may be embodied as integrated components or as separate components. For purposes of comparing various examples, certain aspects and advantages of these examples are described. Not necessarily all such aspects or advantages are achieved by any particular example. Thus, for example, various examples may be carried out in a manner that achieves or optimizes one advantage or group of advantages as taught herein without necessarily achieving other aspects or advantages as may also be taught or suggested herein.
Certain standard anatomical terms of location are used herein to refer to the anatomy of animals, and namely humans, with respect to the preferred examples. Although certain spatially relative terms, such as “outer,” “inner,” “upper,” “lower,” “below,” “above,” “vertical,” “horizontal,” “top,” “bottom,” and similar terms, are used herein to describe a spatial relationship of one device/element or anatomical structure to another device/element or anatomical structure, it is understood that these terms are used herein for ease of description to describe the positional relationship between element(s)/structures(s), as illustrated in the drawings. It should be understood that spatially relative terms are intended to encompass different orientations of the element(s)/structures(s), in use or operation, in addition to the orientations depicted in the drawings. For example, an element/structure described as “above” another element/structure may represent a position that is below or beside such other element/structure with respect to alternate orientations of the subject patient or element/structure, and vice-versa.
In a healthy heart, the heart valves can properly open and close in response to a pressure gradient present during various stages of the cardiac cycle (e.g., relaxation and contraction) to at least partially control the flow of blood to a respective region of the heart and/or to blood vessels. Deoxygenated blood arriving from the rest of the body generally flows into the right side of the heart 1 for transport to the lungs, and oxygenated blood from the lungs generally flows into the left side of the heart 1 for transport to the rest of the body. During ventricular diastole, deoxygenated blood arrive in the right atrium from the inferior vena cava and superior vena cava to flow into the right ventricle 4, and oxygenated blood arrive in the left atrium 2 from the pulmonary veins to flow into the left ventricle 3. During ventricular systole, deoxygenated blood from the right ventricle 4 can flow into the pulmonary trunk 11 for transport to the lungs (e.g., via the left and right pulmonary arteries), and oxygenated blood can flow from the left ventricle 3 to the aorta 12 for transport to the rest of the body.
A number of conditions can contribute to a higher-than-normal pressure in the left atrium 2. Dysfunction of the mitral valve 6 can contribute to elevated left atrial pressure. Conditions such as mitral valve regurgitation and/or stenosis may result in difficulty in pumping blood from the left atrium 2 to the left ventricle 3, contributing to elevated pressure in the left atrium 2. Valve stenosis can cause a valve to become narrowed or obstructed. Mitral valve stenosis can restrict blood flow from the left atrium 2 to the left ventricle 3. Valve regurgitation occurs when a valve does not close properly. For example, regurgitation can occur due to improper coaptation of the valve leaflets, such as due to prolapse of one or more of the valve leaflets. Mitral valve regurgitation can result in blood flow leakage back into the left atrium 2 from the left ventricle 3 when the left ventricle 3 contracts. Restricted flow of blood from the left atrium 2 into the left ventricle 3, and blood flow leakage from the left ventricle 3 back into the left atrium 2 can both contribute to elevated atrial pressure. Dysfunction in the left ventricle 3 can also contribute to elevated left atrial pressure. Elevated left atrial pressure may lead to left atrial enlargement, producing symptoms such as shortness of breath during exertion, fatigue, chest pain, fainting, abnormal heartbeat, and swelling of the legs and feet.
One or more tethers can be deployed to couple a heart valve leaflet and/or heart valve annulus to the heart wall 17 to improve coaptation of the heart valve leaflets. For example, one or more tethers can be deployed to couple both a mitral valve leaflet and a portion of the mitral valve annulus to the left ventricular wall. The tethers are typically advanced from the left ventricle 3 through the heart wall 17 adjacent to the left ventricle 3 and secured to a surgical pad positioned over an externally oriented surface of the heart wall 17 adjacent to the left ventricle 3, such as the left ventricular heart wall. Force exerted upon the location on the heart wall 17 due to tethering thereto of the leaflet and annulus can lead to deformation of that portion of the heart wall 17, contributing to indenting of the heart wall 17. Highly tensioned tethers coupled to the ventricular wall can cause that area of the ventricle to cave in, thereby leading to failure of the repair to restore mitral valve function. For example, force exerted upon the heart wall 17 due to tethering of the annulus can result in pulling inward into the ventricle of the heart wall 17. Deformation of the heart wall 17 can reduce tension in the tethers, thereby preventing desired force from being exerted upon the leaflet and/or annulus to pull in the leaflet and/or annulus for improving leaflet coaptation.
Described herein are systems and methods relating to one or more reinforced surgical pad devices. The reinforced surgical pad devices can comprise a reinforcement member and a surgical pad configured to be associated with the reinforcement member. The reinforcement member and surgical pad can be configured to be positioned over an opening in a target tissue such that one or more tethers extending from the opening in the target tissue can be secured to the surgical pad and/or reinforcement member. The reinforcement member can comprise one or more portions configured to extend laterally beyond an outer edge of the surgical pad. The reinforcement member can be configured to provide a larger area over which forces exerted upon the surgical pad by the tethers coupled thereto can be distributed. Distribution of the forces across a larger area can reduce or eliminate concentration of force upon the target tissue. Concentration of force upon the target tissue can lead to indentation of the target tissue. As described herein, one or more tethers coupled to a heart valve leaflet and/or heart valve annulus can be anchored to a location on the ventricular heart wall. The larger footprint provided by the reinforcement member can facilitate spreading of the forces exerted upon the anchor site across a larger area of the heart wall to prevent or reduce indentation of the heart wall inward toward the ventricle.
The reinforcement member can comprise a central portion and a circumferential portion around the central portion, where the central portion can be configured to be associated with the surgical pad. In some instances, the central portion of the reinforcement member can define an opening extending therethrough. The surgical pad can be configured to be associated with the opening in the central portion. In some instances, the surgical pad can have a same or smaller width and/or length as those of the opening of the reinforcement member such that the surgical pad can be positioned within the opening of the reinforcement member. For example, the surgical pad can be positioned over the opening in the target tissue and the reinforcement member can be positioned over the target tissue such that an inner edge of the central portion defining the opening of the reinforcement member surrounds the opening in the target tissue.
Alternatively, the surgical pad can have a longer width and/or length than the opening in the reinforcement member such that a portion of the surgical pad can be associated with a surface of the reinforcement member configured to be oriented toward the target tissue. For example, the surgical pad and the reinforcement member can be positioned over the target tissue such that a portion of the surgical pad is between the target tissue and the reinforcement member.
In some instances, the circumferential portion of the reinforcement member can comprise a plurality of elongate portions. The plurality of elongate portions can extend radially from the central portion. In some instances, the plurality of radially arranged elongate portions can facilitate desired distribution of force across the target tissue. In some instances, the circumferential portion can comprise an outer circumferential edge portion such that the plurality of elongate portions couples the central portion and the outer circumferential edge portion. For example, the reinforcement member can comprise a plurality of elongate portions extending radially from the central portion to the outer circumferential edge portion. In some instances, the outer circumferential edge portion can be configured to provide additional structural stability for the reinforcement member. In some instances, the reinforcement member can have a hub-and-spoke configuration. In some instances, the reinforcement member can have a hub-and-spoke wheel configuration.
Heart valve repair and/or replacement procedures can be performed to improve or restore valve function. Referring again to
The apical region 19 is schematically shown in
The tethers 20 in
Each tether 20 can comprise a respective elongate portion 22 comprising a proximal portion 24 and a distal portion 26. The proximal portion 24 of a tether 20 can be configured to be coupled to the heart wall 17. The distal portion 26 of a tether 20 can be coupled to the leaflet or annulus of the mitral valve 6. In some examples, the distal portion 26 can be associated with a respective anchor 28 to facilitate securing the tether 20 to the leaflet or the annulus. An anchor 28 can be positioned at least partially over an upper surface of the leaflet or at least partially over an upper surface of the annulus. For example, as shown in
The proximal portion 24 of a tether 20 can be anchored to a portion of the heart wall 17, including a portion of the heart wall 17 at or proximate to the apex 18 of the heart 1, such as in the apical region 19. In some examples, a portion of an elongate portion 22 can extend at least partially through the heart wall 17.
In some instances, the proximal portion 24 of a tether 20 can be coupled to a reinforced surgical pad device 40 to facilitate anchoring the leaflet and annulus of the mitral valve 6 to the heart wall 17. The tethers 20 can couple the mitral valve leaflet and annulus to the reinforced surgical pad device 40, extending from the leaflet and annulus through the left ventricle 3 and opening 50 in the heart wall 17 to the reinforced surgical pad device 40. The reinforced surgical pad device 40 can be positioned over the opening 50 formed in the heart wall 17. In some cases, the reinforced surgical pad device 40 can be positioned over and/or adjacent to the pericardium, epicardium, or myocardium. For example, the proximal portions 24 of the tethers 20 can be coupled to a reinforced surgical pad device 40 on and in contact with the pericardium, epicardium, or myocardium to facilitate anchoring the proximal portions 24 to the target location within the apical region 19 and maintain desired tension in the tethers 20. The proximal portions 24 of the tethers 20 can be extended through the opening 50 in the heart wall 17, and through the reinforced surgical pad device 40.
The reinforced surgical pad device 40 can comprise a reinforcement member 44 and a surgical pad 42. The surgical pad 42 can be positioned over and in contact with the target tissue, for example over the opening 50 in the heart wall 17. The reinforcement member 44 can be positioned over the surgical pad 42 such that the surgical pad 42 is between the reinforcement member 44 and the target tissue. As described herein, in some instances, a reinforcement surgical pad device can comprise a surgical pad disposed within an opening of a reinforcement member, such that the surgical pad can be positioned over the opening 50 in heart wall 17 and in contact with the heart wall 17 while the reinforcement member can be positioned over and in contact with the heart wall 17 and surrounding the opening 50. Although
A reinforcement member can comprise any number of materials configured to provide desired mechanical support at the anchor point, while reducing or preventing damage and/or irritation to the target tissue. The reinforcement member can comprise a rigid and/or semi-rigid biocompatible material. In some instances, the reinforcement member can comprise a synthetic polymer, including for example, one or more of polyethylene, polypropylene, polystyrene, neoprene, and nylon. The reinforcement member can be a polymeric reinforcement member. In some instances, the reinforcement member can comprise a metal, including for example, one or more of aluminum, titanium, stainless steel, and nitinol. For example, the reinforcement member can be a metal or metal alloy reinforcement member. Alternatively, or in combination, the reinforcement member can comprise tissue and/or textile.
A surgical pad can comprise any number of materials. The surgical pad can be configured to comprise sufficient flexibility and mechanical strength to facilitate anchoring one or more tethers to the target site on a ventricular heart wall, while reducing or preventing damage to the target tissue. In some instances, a surgical pad can comprise a flexible material, such as polyurethane (e.g., polyurethane foam), felt, and/or polytetrafluoroethylene (PTFE, e.g., Teflon® PTFE). In some instances, the surgical pad can comprise a pledget.
A surgical pad can have any number of different shapes, sizes and/or configurations. In some instances, the surgical pad can comprise a circular shape. In some instances, the surgical pad can have a rectangular shape. In some instances, the surgical pad can comprise a plurality of pre-formed openings extending therethrough, each opening being configured to receive a corresponding tether (e.g., pair of tether tails) to facilitate threading through of the tether and securing of the tether to the surgical pad.
A reinforced surgical pad device comprising a reinforcement member and a surgical pad configured to be associated with the reinforcement member can be provided as an integrate device. The reinforcement member can be coupled to the surgical pad using any number techniques. The reinforcement member and the surgical pad can be bonded (e.g., using adhesive), molded, fused (e.g., using heat and/or pressure, such as welding, including radiofrequency (RF) welding), and/or mechanically fastened (e.g., sewn), together. In some instances, the reinforcement member and the surgical pad may not be coupled to one another.
The methods, operations, steps, etc. described herein can be performed on a living animal or on a non-living cadaver, cadaver heart, simulator (e.g., with the body parts, tissue, etc. being simulated), etc. For example, methods for treating a patient include methods for simulating the treatment on a simulated patient or anthropogenic ghost, which can include any combination of physical and virtual elements. Examples of physical elements include human or animal cadavers; any portions thereof, including organ systems, whole organs, or tissue; and manufactured elements, which can simulate the appearance, texture, resistance, or other characteristic. Virtual elements can include visual elements provided on a screen, or projected on a surface or volume, including virtual reality and augmented reality implementations. Virtual elements can also simulate other sensory stimuli, including sound, feel, and/or odor.
Any of the various systems, devices, apparatuses, etc. in this disclosure can be sterilized (e.g., with heat, radiation, ethylene oxide, hydrogen peroxide, etc.) to ensure they are safe for use with patients, and the methods herein can comprise sterilization of the associated system, device, apparatus, etc. (e.g., with heat, radiation, ethylene oxide, hydrogen peroxide, etc.).
The term “associated with” is used herein according to its broad and ordinary meaning. For example, where a first feature, element, component, device, or member is described as being “associated with” a second feature, element, component, device, or member, such description should be understood as indicating that the first feature, element, component, device, or member is physically coupled, attached, or connected to, integrated with, embedded at least partially within, or otherwise physically related to the second feature, element, component, device, or member, whether directly or indirectly.
Although the target tissue is described primarily herein as comprising heart ventricular wall tissue, it will be understood that the target tissue can comprise any number of different types of tissues in the heart and/or in other organs.
In some examples, systems, devices, and methods for deploying one or more tethers, as described herein, can comprise one or more features as described in PCT Patent Application No. PCT/US2021/023392, filed Mar. 22, 2021, and entitled “Controlled Suture Tensioning,” which is incorporated herein by reference in its entirety for all purposes.
The reinforcement member 200 can comprise a shape having one or more curved edges, such as a circular or substantially circular shape. The outer edge 210 of the reinforcement member 200 can comprise a circular or substantially circular shape. It will be understood that a reinforcement member can have other shapes. For example, a reinforcement member can comprise an outer edge having an oval shape and/or a polygonal shape, including a rectangular shape.
The central portion 202 can comprise any number of different shapes, including a circular shape. The central portion 202 may or may not have the same shape as the outer edge 210 of the reinforcement member 200. In some instances, both the central portion 202 and the circumferential portion 204 can have a circular shape.
In some instances, the central portion 202 can comprise one or more characteristics different from that of the circumferential portion 204. Referring to
In some instances, the one or more tethers can be coupled to both the surgical pad and the reinforcement member 200. The one or more tethers can be secured to the surgical pad and/or reinforcement member 200 using any number of techniques. As described in further detail herein, securing the one or more tethers to the surgical pad can comprise forming one or more knots using the one or more tethers. In some instances, the reinforcement member 200 can comprise one or more tether securement features (not shown) associated therewith, each tether securement feature being configured to allow a respective tether to be secured thereto. In some instances, the one or more tether securement features can be associated with the circumferential portion 204 of the reinforcement member 200. The one or more tether securement features can be associated with the second surface 208, such as the second surface 208 of the circumferential portion 204. The one or more tether securement features can comprise any number of configurations configured to facilitate securing thereto of a respective tether. As described herein, a tether securement feature can have a “T” shape. It will be understood that a tether securement feature can have other configurations, including for example, a hoop.
The reinforcement member 400 can comprise one or more other features of the reinforcement member 200 described with reference to
In some instances, the surgical pad 502 can be configured to be disposed within the opening 404 of the reinforcement member 400. The surgical pad 502 can be positioned over the opening in the target tissue such that a first surface 504 of the surgical pad 502 can be oriented toward the target tissue and/or opening, and a second surface 506 of the surgical pad 502 can be oriented away from the target tissue and/or opening. The reinforcement member 400 can be positioned to surround the surgical pad 502, the first surface 408 of the reinforcement member 400 being oriented toward the target tissue and the second surface 410 of the reinforcement member 400 being oriented away from the target tissue. The opening 404 of the reinforcement member 400 and the surgical pad 502 can comprise the same or different shape. In some instances, both the opening 404 of the reinforcement member 400 and the surgical pad 502 can comprise a circular shape. One or more lateral dimensions, such as a width and/or a length, of the surgical pad 502 can be the same as or shorter than that of the opening 404 of the reinforcement member 400. For example, a diameter of the surgical pad 502 can be less than or equal to that of the opening 404 of the reinforcement member 400. In some instances, the reinforced surgical pad device 500 can be provided as an integral device. The reinforcement member 400 can be integrated with the surgical pad 502. In some instances, the outer edge 508 of the surgical pad can be coupled to the inner edge 414 of the reinforcement member 400. In some instances, the surgical pad 502 and the reinforcement member 400 can be provided separately.
Alternatively, the reinforced surgical pad device 500 can comprise a surgical pad having a size larger than that of the opening 404 of the reinforcement member 400. An outer edge portion of the surgical pad can be configured to extend laterally beyond the inner edge 414 of the reinforcement member 400. For example, the outer edge portion of the surgical pad can be disposed between the reinforcement member 400 and the target tissue. One or more lateral dimensions, such as a width and/or a length, of the surgical pad can be longer than that of the opening 404 of the reinforcement member 400. For example, a diameter of the surgical pad can be longer than the diameter of the opening 404 of the reinforcement member 400. In some instances, the outer edge portion of the surgical pad can be associated with the reinforcement member 400, such as the first surface 408 of the reinforcement member 400. A second surface of the surgical pad outer edge portion can be coupled to the first surface 408 of the reinforcement member 400.
It will be understood that reinforcement members can comprise a number of different configurations and sizes. A reinforcement member can comprise a polygonal shape, such as a star shape, and/or a rectangular shape, including a square shape. In some instances, a size, such as a width and/or a length, of the reinforcement member can be selected based on patient anatomy.
In some instances, the plurality of elongate portions 612 can extend radially from the central portion 604 of the reinforcement member 602. Each of the plurality of elongate portions 612 can comprise a first end portion 614 oriented toward the central portion 604 and a second end portion 616 oriented away from the central portion 604. In some instances, the first end portion 614 can be adjacent to the central portion 604. In some instances, the second end portion 616 can be adjacent to the outer circumferential edge portion 610. For example, the plurality of elongate portions 612 can extend radially from the central portion 604 to the outer circumferential edge portion 610. The plurality of elongate portions 612 can be arranged radially between the central portion 604 and the outer circumferential edge portion 610 to couple the central portion 604 and the circumferential edge portion 610 to one another.
Although the circumferential portion 608 of the reinforcement member 602 is shown as comprising six elongate portions 612, it will be understood that a circumferential portion can comprise more or fewer elongate portions, such as four or eight. In some instances, the elongate portions 612 can be evenly spaced around the central portion 604. For example, an angle formed by adjacent elongate portions 612 of the reinforcement member 602 can be about 60°.
In some instances, the central portion 604 can comprise a ring-shaped portion. In some instances, the plurality of elongate portions 612 extend radially from the ring-shaped portion. The central portion 604 can comprise an inner edge 618 and an outer edge 620. The inner edge 618 can define the opening 606 of the reinforcement member 602. In some instances, the inner edge 618 can comprise a circular shape. It will be understood that other shapes can also be suitable, including for example, an oval shape and/or a polygonal shape, including a rectangular shape. The outer edge 620 can comprise a plurality of segments. For example, each segment can extend between respective adjacent elongate portions 612. In some instances, the outer edge 620 can comprise a plurality of segments of a circle. For example, the central portion 604 can comprise an annular shape.
In some instances, the outer circumferential edge portion 610 can comprise a ring-shaped portion. The outer circumferential edge portion 610 can comprise an inner edge 622 and an outer edge 624. The inner edge 622 can be oriented toward the central portion 604 and the outer edge 624 can be oriented away from the central portion 604. In some instances, the outer edge 624 can comprise a circular shape. It will be understood that other shapes can also be suitable, including for example, an oval shape and/or a polygonal shape, including a rectangular shape. The inner edge 622 can comprise a plurality of segments. For example, each segment can extend between respective adjacent elongate portions 612, such as between second end portions 616 of respective elongate portions 612. In some instances, the inner edge 622 can comprise a plurality of segments of a circle. For example, the outer circumferential edge portion 610 can comprise an annular shape. In some instances, the reinforcement member 602 can comprise a hub-and-spoke wheel configuration.
In some instances, the reinforcement member 602 can comprise one or more portions having a thickness different from one or more other portions. The one or more of the elongate portions 612 can comprise a longitudinal portion 626 along a longitudinal dimension. The longitudinal portion 626 can have a thickness thicker than adjacent portions 628 that are adjacent to the longitudinal portion 626 along the longitudinal dimension. The longitudinal dimension of an elongate portion 612 can extend between the first and second end portions 612, 614. In some instances, each of the plurality of elongate portions 612 can comprise a longitudinal portion 626 having a thickness thicker than adjacent portions 628. A thickness of an elongate portion 612 can be a dimension extending between opposing portions of the first and second surfaces 630, 632 of the reinforcement member 602. The thickness of the longitudinal portion 626 can provide additional structural support for the elongate portions 612. In some instances, a longitudinal portion 626 can extend along an entire or substantially entire longitudinal dimension, such as a length, of the respective elongate portion 612. For example, the longitudinal portion 626 can extend from the central portion 604 to the outer circumferential edge portion 610.
In some instances, the central portion 604 and/or the outer circumferential edge portion 610 can comprise one or more portions having a thickness thicker than one or more adjacent portions of the reinforcement member 602, including adjacent portions of the central portion 604 and/or adjacent portions of the outer circumferential edge portion 610. For example, the ring-shaped portion of the central portion 604 and/or the ring-shaped portion of the outer circumferential edge portion 610 can have a thickness thicker than one or more adjacent portions of the reinforcement member 602. In some instances, the ring-shaped portion of the central portion 604 can have a thickness thicker than one or more portions of the central portion 604 adjacent to the ring-shaped portion. In some instances, the ring-shaped portion of the outer circumferential edge portion 610 can have a thickness thicker than one or more portions of the outer circumferential edge portion 610 adjacent to the ring-shaped portion.
A lateral dimension, such as a width, of one or more of the elongate portions 612 can vary along a longitudinal dimension of the respective elongate portion 612. The lateral dimension can be perpendicular or substantially perpendicular to the longitudinal dimension and the thickness. In some instances, each of the plurality of elongate portions 612 can have a first end portion 614 having a width wider than that of a second end portion 616.
In some instances, the plurality of elongate portions 612 can comprise the same features. In some instances, six identical elongate portions 612 can be evenly spaced around the central portion 604. The circumferential portion 608 can comprise six openings 634 extending therethrough, each opening 634 defined by lateral edges 636 of respective adjacent elongate portions 612, a respective segment of the outer edge 620 of the central portion 604 and a respective segment of the inner edge 622 of the outer circumferential edge portion 610. In some instances, six identical elongate portions 612 can extend from the central portion 604 to the outer circumferential edge portion 610 to form six openings 634 having the same size and shape.
The surgical pad 650 can be configured to be associated with the central portion 604. In some instances, the surgical pad 650 can be configured to be associated with the inner edge 618 of the central portion 604 defining the opening 606 of the reinforcement member 602. For example, the surgical pad 650 can be positioned over the opening in the target tissue such that the surgical pad 650 can be aligned with the opening in the target tissue. The opening 606 of the reinforcement member 602 can be around the opening in the target tissue. In some instances, the surgical pad 650 can be configured to be disposed within the opening 606 of the reinforcement member 602. In some instances, both the opening 606 of the reinforcement member 602 and the surgical pad 650 can comprise a circular shape. Alternatively, the opening 606 and the surgical pad 650 can comprise different shapes. One or more lateral dimensions, such as a width and/or a length, of the surgical pad 650 can be the same as or shorter than that of the opening 606 of the reinforcement member 602. For example, a diameter of the surgical pad 650 can be less than or equal to that of the opening 606 of the reinforcement member 602. In some instances, the reinforcement member 602 can be integrated with the surgical pad 650, for example, the outer edge 660 of the surgical pad 650 can be coupled to the inner edge 618 of the central portion 604 of the reinforcement member 602. In some instances, the diameter of the surgical pad 650 can be equal to that of the opening 606 of the reinforcement member 602 and the surgical pad 650 can be coupled to the inner edge 618 of the central portion 604. Alternatively, the surgical pad 650 and the reinforcement member 602 can be provided separately.
In some instances, the reinforced surgical pad device 600 can comprise a surgical pad having a size larger than that of the opening 606 of the reinforcement member 602. A width and/or a length, such as a diameter, of the surgical pad can be longer than that of the opening 606. An outer edge portion of the surgical pad can be configured to extend laterally beyond the inner edge 618 of the central portion 604 of the reinforcement member 602. The outer edge portion of the surgical pad can be disposed between the reinforcement member 602 and the target tissue. In some instances, a second surface of the outer edge portion of the surgical pad can be associated with the first surface 630 of the reinforcement member 602.
Referring to
Referring to
In some instances, the plurality of elongate portions 808 can extend radially from the central portion 802 of the reinforcement member 800. Each of the plurality of elongate portions 808 can comprise a first end portion 810 oriented toward the central portion 802 and a second end portion 812 oriented away from the central portion 802. In some instances, the plurality of elongate portions 808 can extend radially from the central portion 802 such that the first end portion 810 can be adjacent to the central portion 802.
Although the circumferential portion 806 of the reinforcement member 800 is shown as comprising eight elongate portions 808, it will be understood that a circumferential portion can comprise more or fewer elongate portions, such as four or six. In some instances, the elongate portions 808 can be evenly spaced around the central portion 802. For example, an angle formed by adjacent elongate portions 808 can be about 80°.
The central portion 802 of the reinforcement member 800 can define an opening 804 extending therethrough. In some instances, the central portion 802 can comprise a ring-shaped portion. The central portion 802 can comprise an inner edge 814 and an outer edge 816. In some instances, the plurality of elongate portions 808 can extend radially from the ring-shaped portion, including from the outer edge 816. The inner edge 814 can define the opening 804. In some instances, the inner edge 814 can comprise a polygonal shape, such as a rectangle. It will be understood that other shapes can also be suitable, including for example, an oval shape and/or circular shape. The outer edge 816 can comprise a plurality of segments. For example, each segment can extend between respective adjacent elongate portions 808. In some instances, the outer edge 816 can comprise a plurality of segments of a rectangle.
In some instances, each of the plurality of elongate portions 808 can comprise a uniform or substantially uniform lateral dimension along the longitudinal dimension. For example, each elongate portion 808 can have a uniform width along the length of the elongate portion 808. Alternatively, the lateral dimension of one or more of the elongate portions 808 can be non-uniform along the longitudinal dimension. For example, the first end portion 810 of each of the plurality of elongate portions 808 can have a width wider than that of the second end portion 812.
The surgical pad 902 can be associated with the central portion 802 of the reinforcement member 800. The surgical pad 902 can have a first surface 904 configured to be oriented toward a target tissue and a second surface 906 configured to be oriented away from the target tissue. A central portion 908 of the surgical pad 902 can be configured to be positioned over an opening in the target tissue. The surgical pad 902 can be configured to be disposed within the opening 804 defined by the central portion 802 of the reinforcement member 800. In some instances, the surgical pad 902 can be coupled to the central portion 802 of the reinforcement member 802, such as the inner edge 814 of the central portion 802 defining the opening 804. The surgical pad 902 can be positioned over an opening in the target tissue, for example such that a central portion 908 of the surgical pad 902 is over the opening, and the inner edge 814 defining the opening 804 of the reinforcement member 800 is over the target tissue and around the opening in the target tissue. The surgical pad 902 and the opening 804 of the reinforcement member 800 can be aligned with the opening in the target tissue. In some instances, the surgical pad 902 can have a shape the same as or similar to that of the opening 804 defined by the central portion 802 of the reinforcement member 800. For example, an outer edge 912 of the surgical pad 902 can have a rectangular shape. In some instances, the surgical pad 902 can have a size the same as or similar to that of the opening 804 of the reinforcement member 800. For example, the outer edge 912 of the surgical pad 902 can be configured to be associated with, such as being coupled to, the inner edge 814 of the central portion 802.
Referring to
Referring to
The surgical pad 1050 can be configured to be associated with the central portion 1004 of the reinforcement member 1002. The surgical pad 1050 can have a first surface 1052 configured to be oriented toward a target tissue and a second surface 1054 configured to be oriented away from the target tissue. A tether 1070 is shown as being coupled to the surgical pad 1050, such as at a location adjacent or proximate to a respective elongate portion 1010 of the reinforcement member 1002. Respective portions of each tether tail 1070a, 1070b of the tether 1070 extending externally from the opening in the target tissue can be advanced through the surgical pad 1050, such as from the first surface 1052 to the second surface 1054 of the surgical pad 1050. A knot can be formed over the second surface 1054 of the surgical pad 1050 using the pair of tether tails 1070a, 1070b. As described in further detail herein, a tether securement feature 1040 can be configured to allow coupling thereto of a respective pair of tether tails 1070a, 1070b such that the tether 1070 can be coupled to both the surgical pad 1050 and the reinforcement member 1002.
In some instances, the surgical pad 1050 can have a size larger than that of the opening 1006 of the reinforcement member 1002. A central portion 1056 of the surgical pad 1050 can be configured to be positioned over an opening in the target tissue. An outer edge portion 1058 can be configured to be associated with the central portion 1004 of the reinforcement member 1002. For example, the outer edge portion 1058 of the surgical pad 1050 can be configured to be coupled to the central portion 1004 of the reinforcement member 1002. A portion of the surgical pad 1050 can be configured to be disposed under the opening 1006 defined by the central portion 1004. For example, the surgical pad 1050 can be positioned over the target tissue and the reinforcement member 1002 can be positioned partially over the surgical pad 1050 such that the outer edge portion 1058 of the surgical pad 1050 is between the reinforcement member 1002, such as a first surface 1020 of the reinforcement member 1002, and the target tissue. In some instances, an outer edge 1060 of the surgical pad 1050 can be configured to be positioned between the reinforcement member 1002, such as the central portion 1004 of the reinforcement member 1002, and the target tissue. The first surface 1020 of the central portion 1004 can comprise at least a portion configured to be coupled to at least a portion of the second surface 1054 of the outer edge portion 1058 of the surgical pad 1050. The opening 1006 of the reinforcement member 1002 can be over the opening in the target tissue such that an inner edge 1016 of the central portion 1004 can be around the opening in the target tissue. The surgical pad 1050 and the opening 1006 of the reinforcement member 1002 can be aligned with the opening in the target tissue.
The surgical pad 1050 may or may not have a shape the same as or similar to that of the opening 1006 defined by the central portion 1004 of the reinforcement member 1002. In some instances, both the opening 1006 defined by the central portion 1004 and the outer edge 1060 of the surgical pad 1050 can have a rectangular shape.
Referring to
As shown in
The reinforcement member 1002 can have one or more other features of the reinforcement member 800 described with reference to
In some instances, the outer circumferential edge portion 1108 can comprise a ring-shaped portion. The outer circumferential edge portion 1108 can comprise an inner edge 1112 oriented toward the central portion 1102 and the outer edge 1114 oriented away from the central portion 1102. In some instances, the outer edge 1114 can comprise a polygonal shape, including a square shape. It will be understood that other shapes can also be suitable, including for example, shapes comprising one or more curved sides, such as a circular and/or an oval shape. The inner edge 1112 can comprise a plurality of segments. For example, each segment can extend between respective adjacent elongate portions 1110. In some instances, the inner edge 1112 can comprise a plurality of segments of a circle.
The central portion 1102 can define an opening 1104 extending therethrough. In some instances, the central portion 1102 can comprise a ring-shaped portion. In some instances, the plurality of elongate portions 1110 can be arranged in a radial pattern between the ring-shaped portion and the outer circumferential edge portion 1108. The plurality of elongate portions 1110 can extend radially from the ring-shaped portion. The central portion 1102 can comprise an inner edge 1116 and an outer edge 1118. The inner edge 1116 can define the opening 1104 of the reinforcement member 1100. In some instances, the inner edge 1116 of the central portion 1102 can comprise a circular shape. It will be understood that other shapes can also be suitable, including for example, an oval and/or a polygonal shape, such as a rectangular shape. The outer edge 1118 can comprise a plurality of segments. For example, each segment can extend between respective adjacent elongate portions 1110. In some instances, the outer edge 1118 can comprise a plurality of segments of a circle. For example, the central portion 1102 can comprise an annular shape.
Each of the plurality of elongate portions 1110 comprise a first end portion 1120 oriented toward the central portion 1102 and a second end portion 1122 oriented away from the central portion 1102. The plurality of elongate portions 1110 can be arranged in a radial pattern to couple the central portion 1102 and the outer circumferential edge portion 1108. In some instances, the first end portion 1120 can be adjacent to the central portion 1102. In some instances, the second end portion 1122 can be adjacent to the outer circumferential edge portion 1108. For example, the plurality of elongate portions 1110 can extend radially from the central portion 1102 to the outer circumferential edge portion 1108. The plurality of elongate portions 1110 can extend from the outer edge 1118 of the ring-shaped central portion to the inner edge 1112 of the outer circumferential edge portion 1108. The first end portion 1120 of each elongate portion 1110 can be adjacent to respective segments of the outer edge 1118 of the central portion 1102. The second end portion 1122 of each elongate portion 1110 can be adjacent to respective segments of the inner edge 1116 of the outer circumferential edge portion 1108.
Although the circumferential portion 1106 of the reinforcement member 1100 is shown as comprising four elongate portions 1110, it will be understood that a circumferential portion can comprise more or fewer elongate portions, such as six or eight elongate portions. In some instances, the elongate portions 1110 can be evenly spaced around the central portion 1102. An angle formed by adjacent elongate portions 1110 of the reinforcement member 1100 can be about 90°.
In some instances, a lateral dimension, such as a width, of the outer circumferential edge portion 1108 can be longer than the longitudinal dimension, such as a length, of an elongate portion 1110. The lateral dimension of the outer circumferential edge portion 1108 can be a dimension extending between two opposing positions of the inner edge 1112 and outer edge 1114 of the circumferential edge portion 1108.
The circumferential portion 1106 can comprise four openings 1128 extending therethrough, each opening 1128 defined by lateral edges of respective adjacent elongate portions 1110, a respective segment of the outer edge 1118 of the central portion 1102 and a respective segment of the inner edge 1112 of the outer circumferential edge portion 1108. In some instances, the plurality of elongate portions 1110 can comprise the same features and can be evenly spaced around the central portion 1102 such that the four openings 1128 can comprise the same size and shape.
The surgical pad 1202 can have a first surface 1204 configured to be oriented toward a target tissue and a second surface 1206 configured to be oriented away from the target tissue. A central portion 1208 of the surgical pad 1202 can be configured to be positioned over an opening in the target tissue. The surgical pad 1202 can be configured to be disposed within the opening 1104 defined by the central portion 1102. The surgical pad 1202 can be positioned over an opening in the target tissue such that the opening 1104 of the reinforcement member 1100 is over and around the opening in the target tissue. The surgical pad 1202 and the opening 1104 of the reinforcement member 1100 can be aligned with the opening in the target tissue. In some instances, the surgical pad 1202 can have a shape the same as or similar to that of the opening 1104 defined by the central portion 1102 of the reinforcement member 1100. For example, an outer edge 1212 of the surgical pad 1202 can have a circular or substantially circular shape. In some instances, the surgical pad 1202 can have a size the same as or similar to that of the opening 1104 of the reinforcement member 1100. For example, the outer edge 1212 of the surgical pad 1202 can be configured to be associated with, such as coupled to, the inner edge 1116 of the central portion 1102.
Referring to
Referring to
Each of the plurality of elongate portions 1312 can comprise a first end portion 1314 oriented toward the central portion 1304 and a second end portion 1316 oriented toward the outer circumferential edge portion 1310. Each of the plurality of tether securement features 1340 can be disposed between a second end portion 1316 of a respective elongate portion 1312 and an outer edge 1324 of the outer circumferential edge portion 1310.
The surgical pad 1350 can be configured to be associated with the central portion 1304 of the reinforcement member 1302. For example, the surgical pad 1350 can be configured to be coupled to the central portion 1304 of the reinforcement member 1302. The surgical pad 1350 can have a first surface 1352 configured to be oriented toward a target tissue and a second surface 1354 configured to be oriented away from the target tissue. In some instances, the surgical pad 1350 can have a size larger than that of the opening 1306 of the reinforcement member 1302. A central portion 1356 of the surgical pad 1350 can be configured to be positioned over an opening in the target tissue. An outer edge portion 1358 of the surgical pad 1350 can be configured to be associated with the central portion 1304 of the reinforcement member 1302. A portion of the surgical pad 1350 can be configured to be disposed under the opening 1306 defined by the central portion 1304. For example, the surgical pad 1350 can be positioned over the target tissue and the reinforcement member 1302 can be positioned partially over the surgical pad 1350 such that the outer edge portion 1358 of the surgical pad 1350 is between the reinforcement member 1302, including the first surface 1326 of the reinforcement member 1302, and the target tissue. An outer edge 1360 of the surgical pad 1350 can be configured to be positioned between the central portion 1304 of the reinforcement member 1302 and the target tissue. An inner edge 1318 of the central portion 1304 defining the opening 1306 of the reinforcement member 1302 can be over the target tissue, and over and in contact with at least a portion of the outer edge portion 1358 of the surgical pad 1350. The inner edge 1318 can be around the opening in the target tissue. The surgical pad 1350 and the opening 1306 of the reinforcement member 1302 can be aligned with the opening in the target tissue.
The surgical pad 1350 may or may not have a shape the same as or similar to that of the opening 1306 defined by the central portion 1304 of the reinforcement member 1302. In some instances, the opening 1306 defined by the central portion 1304 and the outer edge 1360 of the surgical pad 1350 can have a circular or substantially circular shape.
Referring again to
Referring to
The reinforcement member 1302 can have one or more other features of the reinforcement member 1100 described with reference to
In some instances, the reinforcement member 1402 and surgical pad 1450 can have the same shape. For example, the reinforcement member 1402 and surgical pad 1450 can each comprise a rectangular shape. In some instances, the reinforcement member 1402 and surgical pad 1450 can have the same size, such as having the same footprint. For example, a lateral dimension and a longitudinal dimension of each of the reinforcement member 1402 and surgical pad 1450 can be the same or similar. An outer edge 1408 of the reinforcement member 1402 can be aligned with an outer edge 1456 of the surgical pad 1450 while the surgical pad 1450 is coupled to the first surface 1404 of the reinforcement member 1402. A lateral dimension for each of the reinforcement member 1402 and the surgical pad 1450 can be a dimension extending between opposing portions of the respective outer edges 1408, 1456. A longitudinal dimension of each of the reinforcement member 1402 and surgical pad 1450 can be a dimension extending between opposing portions of the respective outer edges 1408, 1456 and which is perpendicular or substantially perpendicular to the lateral dimension.
It will be understood that a reinforcement member and surgical pad can each comprise another polygonal shape, such as a square. In some instances, a reinforcement member and surgical pad can each comprise a shape having one or more curves, including a circle or oval. For example, the reinforcement member and surgical pad can have the same or similar diameters.
In some instances, a reinforced surgical pad device can comprise a uniform material. For example, a reinforced surgical pad device can have one or more shapes as described herein, while comprising a material having sufficient mechanical strength to prevent or reduce deformation, warping and/or withstand the forces of the tethers. A reinforced surgical pad can have one or more configurations as described herein and a uniform material throughout, such as rather than a reinforcement member distinct from a surgical pad, and configured to prevent or reduce caving inward of a heart wall.
In block 1504, the process can involve positioning the surgical pad and the reinforcement member over an opening in a target tissue. The surgical pad and/or the reinforcement member can be over and in contact with an externally oriented surface of the target tissue. In block 1506, the process can involve securing respective portions of a plurality of tethers extending from the opening in the target tissue to corresponding portions of the surgical pad. In block 1508, the process can involve securing the respective portions of the plurality of tethers to corresponding portions of the reinforcement member. In some instances, securing the respective portions of the plurality of tethers to corresponding portions of the reinforcement member can comprise securing the respective portions of the plurality of tethers to corresponding tether securement features of the reinforcement member. Alternatively, or in combination, securing the respective portions of the plurality of tethers to corresponding portions of the reinforcement member can comprise wrapping a portion of the plurality of tethers around a portion of the reinforcement member.
Providing the reinforcement member and the surgical pad can comprise providing a reinforcement member comprising a central portion defining an opening extending therethrough, and providing the surgical pad associated with the opening of the reinforcement member. In some instances, providing the surgical pad associated with the opening of the reinforcement member comprises providing the surgical pad disposed within the opening of the reinforcement member.
In some instances, positioning the surgical pad and the reinforcement member over the opening in the target tissue can comprise aligning the surgical pad and the opening of the reinforcement member with the opening in the target tissue. Aligning the surgical pad and the opening of the reinforcement member with the opening in the target tissue can comprise positioning the surgical pad at least partially over the opening in the target tissue. The reinforcement member can be positioned such that the opening in the reinforcement member surrounds the opening in the target tissue. In some instances, the surgical pad can have a footprint larger than that of the opening in the reinforcement member. Positioning the surgical pad and the reinforcement member over the opening in the target tissue can comprise positioning at least a portion of the surgical pad between the reinforcement member and the target tissue. For example, the surgical pad can be aligned with the opening of the reinforcement member and an outer edge portion of the surgical pad can be between the target tissue and the reinforcement member. Securing respective portions of the plurality of tethers to corresponding portions of the surgical pad can comprise advancing the respective portions of the plurality of tethers through the surgical pad. For example, each of the plurality of tethers can be advanced from a first surface of the surgical pad configured to be oriented toward the target tissue through the surgical pad to a second surface of the surgical pad. In some instances, a knot can be formed over the second surface with a respective tether to secure the tether to the surgical pad.
In some instances, providing the reinforcement member and the surgical pad can comprise providing the surgical pad positioned between the target tissue and the reinforcement member. For example, positioning the surgical pad and the reinforcement member over the opening in the target tissue can comprise aligning the surgical pad and the central portion of the reinforcement member with the opening in the target tissue. Positioning the surgical pad and the reinforcement member over the opening in the target tissue can comprise positioning at least a portion of the surgical pad between the central portion of the reinforcement member and the target tissue. Securing respective portions of the plurality of tethers to corresponding portions of the surgical pad can comprise advancing respective portions of the plurality of tethers through the central portions of the reinforcement member and the surgical pad.
The surgical pad and the reinforcement member can be positioned over heart wall tissue. For example, positioning the surgical pad and the reinforcement member over an opening in a target tissue can comprise positioning the surgical pad and the reinforcement member over an externally oriented surface of the heart wall tissue.
Example 1: A reinforced surgical pad device, comprising:
Example 2: The device of any example herein, in particular example 1, wherein the surgical pad is configured to be positioned between the target tissue and the reinforcement member.
Example 3: The device of any example herein, in particular example 1, wherein the central portion of the reinforcement member defines an opening extending therethrough, the opening of the reinforcement member being configured to be aligned with the surgical pad and the opening in the target tissue.
Example 4: The device of any example herein, in particular example 3, wherein the surgical pad is configured to be disposed within the opening of the reinforcement member.
Example 5: The device of any example herein, in particular example 3, wherein an outer edge portion of the surgical pad is configured to be disposed between the reinforcement member and the target tissue.
Example 6: The device of any example herein, in particular examples 3 to 5, wherein the circumferential portion of the reinforcement member comprises a plurality of elongate portions extending radially from the central portion of the reinforcement member.
Example 7: The device of any example herein, in particular example 6, wherein the central portion comprises a ring-shaped portion.
Example 8: The device of any example herein, in particular example 7, wherein the plurality of elongate portions extends radially from the ring-shaped portion.
Example 9: The device of any example herein, in particular examples 6 to 8, wherein the circumferential portion comprises four elongate portions evenly spaced around the central portion.
Example 10: The device of any example herein, in particular examples 6 to 8, wherein the circumferential portion comprises six elongate portions evenly spaced around the central portion.
Example 11: The device of any example herein, in particular examples 6 to 8, wherein the circumferential portion comprises eight elongate portions evenly spaced around the central portion.
Example 12: The device of any example herein, in particular examples 6 to 11, wherein each of the plurality of elongate portions comprises a uniform width along a longitudinal axis.
Example 13: The device of any example herein, in particular examples 6 to 11, wherein each of the plurality of elongate portions comprises a first end portion oriented toward the central portion and a second end portion oriented away from the central portion, the first end portion having a wider width than the second end portion.
Example 14: The device of any example herein, in particular examples 6 to 13, wherein each of the plurality of elongate portions comprise a uniform thickness along both a longitudinal axis and a lateral axis.
Example 15: The device of any example herein, in particular examples 6 to 13, wherein each of the plurality of elongate portions comprise a longitudinal portion along a longitudinal dimension having a thickness thicker than adjacent portions along the longitudinal dimension.
Example 16: The device of any example herein, in particular examples 6 to 15, wherein the reinforcement member comprises a tether securement feature associated with each of the plurality of elongate portions.
Example 17: The device of any example herein, in particular example 16, wherein each of the plurality of elongate portions comprise a first end portion oriented toward the central portion and a second end portion oriented away from the central portion, the tether securement feature being associated with the second end portion of each of the plurality of elongate portions.
Example 18: The device of any example herein, in particular example 6, wherein the circumferential portion comprises an outer circumferential edge portion, the plurality of elongate portions extending between the central portion and the outer circumferential edge portion.
Example 19: The device of any example herein, in particular example 18, wherein the outer circumferential edge portion comprises an inner edge and an outer edge, the outer edge comprising a square shape and the inner edge comprising a plurality of segments of a circle, each segment of the circle extending between respective adjacent elongate portions.
Example 20: The device of any example herein, in particular example 18, wherein the outer circumferential edge portion comprises an inner edge and an outer edge, the outer edge comprising a circular shape and the inner edge comprising a plurality of segments of a circle, each segment of the circle extending between respective adjacent elongate portions.
Example 21: The device of any example herein, in particular examples 18 to 20, wherein the reinforcement member comprises a plurality of tether securement features, the plurality of tether securement features being associated with the outer circumferential edge portion.
Example 22: The device of any example herein, in particular example 21, wherein each of the plurality of elongate portions comprise a first end portion oriented toward the central portion and a second end portion oriented toward the outer circumferential edge portion, each of the plurality of tether securement features being disposed between a second end portion of a respective elongate portion and an outer edge of the outer circumferential edge portion.
Example 23: A reinforcement member, comprising:
Example 24: The member of any example herein, in particular example 23, wherein the central portion of the reinforcement member defines an opening extending therethrough, the opening of the reinforcement member and the surgical pad being configured to be aligned with the opening in the target tissue.
Example 25: The member of any example herein, in particular example 24, wherein the central portion comprises a ring-shaped portion.
Example 26: The member of any example herein, in particular example 24 or 25, wherein the circumferential portion of the reinforcement member comprises a plurality of elongate portions extending radially from the central portion of the reinforcement member.
Example 27: The member of any example herein, in particular example 26, wherein the plurality of elongate portions extends radially from the ring-shaped portion.
Example 28: The member of any example herein, in particular examples 25 to 27, wherein the reinforcement member comprises a tether securement feature associated with each of the plurality of elongate portions.
Example 29: The member of any example herein, in particular example 28, wherein each of the plurality of elongate portions comprise a first end portion oriented toward the central portion and a second end portion oriented away from the central portion, the tether securement feature being associated with the second end portion of each of the plurality of elongate portions.
Example 30: The member of any example herein, in particular examples 26 to 29, wherein the circumferential portion comprises an outer circumferential edge portion, the plurality of elongate portions extending between the central portion and the outer circumferential edge portion.
Example 31: The member of any example herein, in particular example 30, wherein the outer circumferential edge portion comprises an inner edge and an outer edge, the outer edge comprising a square shape and the inner edge comprising a plurality of segments of a circle, each segment of the circle extending between respective adjacent elongate portions.
Example 32: The member of any example herein, in particular example 30, wherein the outer circumferential edge portion comprises an inner edge and an outer edge, the outer edge comprising a circular shape and the inner edge comprising a plurality of segments of a circle, each segment of the circle extending between respective adjacent elongate portions.
Example 33: The member of any example herein, in particular examples 30 to 32, wherein the reinforcement member comprises a plurality of tether securement features, the plurality of tether securement features being associated with the outer circumferential edge portion.
Example 34: The member of any example herein, in particular example 33, wherein each of the plurality of elongate portions comprise a first end portion oriented toward the central portion and a second end portion oriented toward the outer circumferential edge portion, each of the plurality of tether securement features being disposed between a second end portion of a respective elongate portion and an outer edge of the outer circumferential edge portion.
Example 35: A method, comprising:
Example 36: The method of any example herein, in particular example 35, wherein securing the respective portions of the plurality of tethers to corresponding portions of the reinforcement member comprises securing the respective portions of the plurality of tethers to corresponding tether securement features of the reinforcement member.
Example 37: The method of any example herein, in particular example 35 or 36, wherein:
Example 38: The method of any example herein, in particular example 37, wherein providing the surgical pad associated with the opening of the reinforcement member comprises providing the surgical pad disposed within the opening of the reinforcement member.
Example 39: The method of any example herein, in particular example 37, wherein providing the surgical pad associated with the opening of the reinforcement member comprises providing the surgical pad aligned with the opening of the reinforcement member and providing an outer edge portion of the surgical pad between the target tissue and the reinforcement member.
Example 40: The method of any example herein, in particular example 35, wherein:
Example 41: The method of any example herein, in particular example 40, wherein positioning the surgical pad and the reinforcement member over the opening in the target tissue comprises positioning the surgical pad and the reinforcement member over heart wall tissue.
The above method(s) can be performed on a living animal or on a simulation, such as on a cadaver, cadaver heart, anthropomorphic ghost, simulator (e.g., with body parts, heart, tissue, etc. being simulated).
Depending on the example, certain acts, events, or functions of any of the processes or algorithms described herein can be performed in a different sequence, may be added, merged, or left out altogether. Thus, in certain examples, not all described acts or events are necessary for the practice of the processes.
Conditional language used herein, such as, among others, “can,” “could,” “might,” “may,” “e.g.,” and the like, unless specifically stated otherwise, or otherwise understood within the context as used, is intended in its ordinary sense and is generally intended to convey that certain examples include, while other examples do not include, certain features, elements and/or steps. Thus, such conditional language is not generally intended to imply that features, elements and/or steps are in any way required for one or more examples or that one or more examples necessarily include logic for deciding, with or without author input or prompting, whether these features, elements and/or steps are included or are to be performed in any particular example. The terms “comprising,” “including,” “having,” and the like are synonymous, are used in their ordinary sense, and are used inclusively, in an open-ended fashion, and do not exclude additional elements, features, acts, operations, and so forth. Also, the term “or” is used in its inclusive sense (and not in its exclusive sense) so that when used, for example, to connect a list of elements, the term “or” means one, some, or all of the elements in the list. Conjunctive language such as the phrase “at least one of X, Y and Z,” unless specifically stated otherwise, is understood with the context as used in general to convey that an item, term, element, etc. may be either X, Y or Z. Thus, such conjunctive language is not generally intended to imply that certain examples require at least one of X, at least one of Y and at least one of Z to each be present.
It should be appreciated that in the above description of examples, various features are sometimes grouped together in a single example, Figure, or description thereof for the purpose of streamlining the disclosure and aiding in the understanding of one or more of the various inventive aspects. This method of disclosure, however, is not to be interpreted as reflecting an intention that any claim require more features than are expressly recited in that claim. Moreover, any components, features, or steps illustrated and/or described in a particular example herein can be applied to or used with any other example(s). Further, no component, feature, step, or group of components, features, or steps are necessary or indispensable for each example. Thus, it is intended that the scope of the disclosure and claims below should not be limited by the particular examples described above, but should be determined only by a fair reading of the claims that follow.
It should be understood that certain ordinal terms (e.g., “first” or “second”) may be provided for ease of reference and do not necessarily imply physical characteristics or ordering. Therefore, as used herein, an ordinal term (e.g., “first,” “second,” “third,” etc.) used to modify an element, such as a structure, a component, an operation, etc., does not necessarily indicate priority or order of the element with respect to any other element, but rather may generally distinguish the element from another element having a similar or identical name (but for use of the ordinal term). In addition, as used herein, indefinite articles (“a” and “an”) may indicate “one or more” rather than “one.” Further, an operation performed “based on” a condition or event may also be performed based on one or more other conditions or events not explicitly recited.
Unless otherwise defined, all terms (including technical and scientific terms) used herein have the same meaning as commonly understood by one of ordinary skill in the art to which example examples belong. It be further understood that terms, such as those defined in commonly used dictionaries, should be interpreted as having a meaning that is consistent with their meaning in the context of the relevant art and not be interpreted in an idealized or overly formal sense unless expressly so defined herein.
The spatially relative terms “outer,” “inner,” “upper,” “lower,” “below,” “above,” “vertical,” “horizontal,” and similar terms, may be used herein for ease of description to describe the relations between one element or component and another element or component as illustrated in the drawings. It be understood that the spatially relative terms are intended to encompass different orientations of the device in use or operation, in addition to the orientation depicted in the drawings. For example, in the case where a device shown in the drawing is turned over, the device positioned “below” or “beneath” another device may be placed “above” another device. Accordingly, the illustrative term “below” may include both the lower and upper positions. The device may also be oriented in the other direction, and thus the spatially relative terms may be interpreted differently depending on the orientations.
Unless otherwise expressly stated, comparative and/or quantitative terms, such as “less,” “more,” “greater,” and the like, are intended to encompass the concepts of equality. For example, “less” can mean not only “less” in the strictest mathematical sense, but also, “less than or equal to.”
This application is a continuation of International Patent Application No. PCT/US2022/051141, filed Nov. 29, 2022, which claims the benefit of U.S. Patent Application No. 63/264,919, filed Dec. 3, 2021, the entire disclosures all of which are incorporated by reference for all purposes.
Number | Date | Country | |
---|---|---|---|
63264919 | Dec 2021 | US |
Number | Date | Country | |
---|---|---|---|
Parent | PCT/US2022/051141 | Nov 2022 | WO |
Child | 18731597 | US |